What they found that, at least for the gastrointestinal tract, oral administration of BPC 157 seems to be favorable Pentadecapeptide BPC 157 and the central nervous system (link) This great study was designed to look at the effectiveness of BPC-157 on things like Behavioral Disorders, Brain Lesions, and Spinal Cord Injury
But then what happens as soon as there's a change in power down the road
Dr Piatkowski said a "multi-pronged" response was needed, as peptide use in the community grew
BPC-157 (Body Protection Compound-157) shows remarkable potential for hip injury recovery based on extensive animal research and growing anecdotal evidence from users worldwide
In April 2026, the FDA announced that its Pharmacy Compounding Advisory Committee (PCAC) will meet on July 23 and 24, 2026, to discuss several peptide-related bulk drug substances for possible inclusion on the 503A Bulks List